Skip to main content
UTI
NYSE Trade & Services

Officer/Director Jerome Grant Files to Sell $3.9M in Shares

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$41.35
Mkt Cap
$2.277B
52W Low
$21.29
52W High
$45.74
52W Position info
94% above low
Off High info
9.6% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

UTI sits 94% above its 52-week low of $21.29.

Summary

Officer and Director Jerome Alan Grant has filed to sell $3.9 million in company stock, adding to recent insider selling activity.


Key Events · Ownership and Investor Activity · UTI

  • Officer/Director Intent to Sell

    Jerome Alan Grant, an Officer and Director, filed a Form 144 to sell 94,500 shares of common stock.

  • Significant Value

    The proposed sale has an approximate market value of $3.91 million.

  • Shares from Compensation

    The shares intended for sale were acquired through restricted stock vesting as compensation.

  • Part of Broader Insider Distribution

    This filing contributes to a recent pattern of insider selling, with net insider sales of over $125 million in the last 90 days.


Analysis · UTI · Trade & Services

An officer and director, Jerome Alan Grant, has filed a Form 144 indicating an intent to sell approximately $3.9 million worth of common stock. This sale represents a portion of shares acquired through restricted stock vesting. While part of an ongoing pattern of insider sales, this specific filing adds to the overall distribution signal from insiders.

At the time of this filing, UTI was trading at $41.35 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $21.29 to $45.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UTI - Latest Insights

UTI
Jun 30, 2026, 8:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $42.77
Real-time Price: $42.77 info
Change: $0 (0%) info
Market Cap: $2.355B info
UTI
Jun 29, 2026, 4:12 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.35
Real-time Price: $42.77 info
Change: +$1.42 (+3%) info
Market Cap: $2.355B info
UTI
Jun 10, 2026, 5:59 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $39.55
Real-time Price: $42.77 info
Change: +$3.22 (+8%) info
Market Cap: $2.355B info
UTI
Jun 10, 2026, 5:52 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $39.55
Real-time Price: $42.77 info
Change: +$3.22 (+8%) info
Market Cap: $2.355B info
UTI
Jun 08, 2026, 6:42 PM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $41.00
Real-time Price: $42.77 info
Change: +$1.77 (+4%) info
Market Cap: $2.355B info
UTI
May 07, 2026, 8:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.65
Real-time Price: $42.77 info
Change: +$7.12 (+20%) info
Market Cap: $2.355B info
UTI
May 06, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $35.27
Real-time Price: $42.77 info
Change: +$7.50 (+21%) info
Market Cap: $2.355B info
UTI
May 06, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.50
Real-time Price: $42.77 info
Change: +$7.27 (+20%) info
Market Cap: $2.355B info
UTI
Mar 06, 2026, 6:00 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $34.99
Real-time Price: $42.77 info
Change: +$7.78 (+22%) info
Market Cap: $2.355B info
UTI
Mar 04, 2026, 8:16 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $35.82
Real-time Price: $42.77 info
Change: +$6.95 (+19%) info
Market Cap: $2.355B info